Role of simvastatin and methyl-beta-cyclodextrin [corrected] on inhibition of poliovirus infection.
Cells exposed to simvastatin or to methyl-beta-cyclodextrin show reduced poliovirus infection, without alteration in virus binding or on the kinetics of genome entry, suggesting that the steps which are altered are those post uncoating and genome entry. Reduction of infection by cyclodextrin is reversed by increasing MOI whereas that produced by simvastatin treatment is not, suggesting that the effects on infection are not due to a reduction in cholesterol. The differences in the characteristics of inhibition can be explained by the differential effects of the compounds. Cyclodextrin inhibits the store-operated calcium channels, suggesting that reduction in infection is through translational inhibition. Simvastatin produces vesicles from internal membranes which cannot sustain viral RNA synthesis, reducing infection through reduced transcription. The results indicate that the impact on viral infection by the cholesterol-modifying agents is due to the cellular changes produced rather than due to disruption of the cholesterol-rich domains.
Liu
Shumei
S
Department of Cell Biology, Harvard Medical School, Cambridge, MA 02116, USA.
Rodriguez
Ana V
AV
Tosteson
Magdalena T
MT
D000998:Antiviral Agents / Q000008:administration & dosage; D002470:Cell Survival / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D006367:HeLa Cells; D006801:Humans; D011051:Poliomyelitis / Q000517:prevention & control* / Q000821:virology*; D017955:Poliovirus / Q000187:drug effects* / Q000502:physiology*; D019821:Simvastatin / Q000008:administration & dosage*; D014779:Virus Replication / Q000187:drug effects*; D047392:beta-Cyclodextrins / Q000008:administration & dosage*
D000998:Antiviral Agents; D047392:beta-Cyclodextrins; C108732:methyl-beta-cyclodextrin; D019821:Simvastatin